InvestorsHub Logo
Followers 120
Posts 19689
Boards Moderated 0
Alias Born 08/27/2005

Re: jour_trader post# 296918

Tuesday, 08/07/2018 2:01:40 AM

Tuesday, August 07, 2018 2:01:40 AM

Post# of 410863
If results of the NIH study show any kind of promise at all for PD Elite can call it a bonus round. All other PD drugs attempting to slow PD down
are not isradipine. There is a reason the NIH conducted this series of studies which cost in the millions. It may be considered amazing if it were beneficial for PD, but not totally unusual. Botox a cosmetic formulation has been proven effective for migraine headaches. Who'd a thought? So it is possible this CCB has some sort of property that can delay (slow down) the onset of PD while extending the lives of those that have PD.

In a short period of time the study results will begin to leak out.
If isradipine is found to be a dud with PD Elite still has bomb shell ANDAs waiting in the wings. There in lies the beauty of this drug. A bonus round for Elite still remains very possible.


I would say that the time to load up on more shares is now. Wish I had the cash because that is what I would be doing. Adding more to my Roth. $6500 more.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News